Professor, Internal Medicine, Ohio State University College of Medicine
Oncology
Dr. Maura L. Gillison, MD
|
|
Give Review
Maura Gillison is an expert in the field of Oncology. He went to medical school at Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is one of the top medical schools in the US. Johns Hopkins University School of Medicine is ranked 3 in research and 29 in primary care medicine He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Elected Member". Maura L. Gillison is also published. He has 76 publications published. The lastest publication: "Human herpesvirus-8.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Gender differences in risk factors and natural history of Oral human papillomavirus (HPV) infection.
- Dose De-escalation in Human Papillomavirus-Associated Oropharyngeal Cancer: First Tracks on Powder.
- Anticipation of the Impact of Human Papillomavirus on Clinical Decision Making for the Head and Neck Cancer Patient.
- High Oral Human Papillomavirus Type 16 Load Predicts Long-term Persistence in Individuals With or at Risk for HIV Infection.
- Oropharyngeal Cancer survivorship in Denmark, 1977-2012.
- Institutional Clinical Trial Accrual Volume and Survival of Patients With Head and Neck Cancer.
- Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation The...
- Tobacco use and Oral HPV-16 infection.
- Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522.
- Postoperative Chemoradiotherapy and Cetuximab for High-Risk Squamous Cell Carcinoma of the Head and Neck: Radiation Therapy Oncology Group RTOG-0234.
- The use of ultrasound in the search for the primary site of unknown primary head and neck squamous Cell cancers.
- Oral Human Papillomavirus (HPV) Infection in HPV-Positive Patients With Oropharyngeal Cancer and Their Partners.
- DEK promotes HPV-positive and -negative head and neck cancer Cell proliferation.
- Transcervical ultrasonography is feasible to visualize and evaluate base of tongue Cancers.
- Comprehensive control of human papillomavirus infections and related diseases.
- Worldwide Trends in Incidence Rates for Oral Cavity and Oropharyngeal Cancers.
- Genome-wide analysis of HPV integration in human Cancers reveals recurrent, focal genomic instability.
- Head and Neck Cancers, Version 2.2013.
- Natural history of anal vs Oral HPV infection in HIV-infected men and women.
- Comparative epidemiology of HPV infection and associated Cancers of the head and neck and cervix.
- Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous Cell carcinomas.
- Human papillomavirus and diseases of the upper airway: head and neck Cancer and respiratory papillomatosis.
- The fanconi Anemia pathway limits human papillomavirus replication.
- The prevalence and incidence of Oral human papillomavirus infection among young men and women, aged 18-30 years.
- Tobacco Smoking and Increased Risk of Death and Progression for Patients With p16-Positive and p16-Negative Oropharyngeal Cancer.
- Risk factors for Oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults.
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States.
- Associations between Oral HPV16 infection and cytopathology: evaluation of an oropharyngeal "pap-test equivalent" in high-risk populations.
- Head and neck Cancers.
- Assessment of human papillomavirus in Lung tumor tissue.
- Human papillomavirus and survival of patients with oropharyngeal Cancer.
- No role for human papillomavirus in esophageal squamous Cell carcinoma in China.
- Human papillomavirus in head and neck Cancer: its role in pathogenesis and clinical implications.
- Head and neck squamous Cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, ...
- Oropharyngeal Cancer: a potential consequence of concomitant HPV and HIV infection.
- Oral sexual behaviors associated with prevalent Oral human papillomavirus infection.
- Human papillomavirus in HNSCC: recognition of a distinct disease type.
- Burden of potentially human papillomavirus-associated Cancers of the oropharynx and oral cavity in the US, 1998-2003.
- HPV prophylactic vaccines and the potential prevention of noncervical Cancers in both men and women.
- Oral human papillomavirus infection before and after treatment for human papillomavirus 16-positive and human papillomavirus 16-negative head and neck squamous Cell ca...
- Human papillomavirus-related diseases: oropharynx Cancers and potential implications for adolescent HPV vaccination.
- Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck Cancers.
- Improved survival of patients with human papillomavirus-positive head and neck squamous Cell carcinoma in a prospective clinical trial.
- Incidence trends for human papillomavirus-related and -unrelated oral squamous Cell carcinomas in the United States.
- Current topics in the epidemiology of oral cavity and oropharyngeal Cancers.
- Six-month natural history of Oral versus cervical human papillomavirus infection.
- Case-control study of human papillomavirus and oropharyngeal Cancer.
- Human retinoblastoma is not caused by known pRb-inactivating human DNA tumor viruses.
- Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous Cell carcinoma of the head and neck.
- Human papillomavirus and prognosis of oropharyngeal squamous Cell carcinoma: implications for clinical research in head and neck cancers.
- Delayed diagnosis and elevated mortality in an urban population with HIV and lung Cancer: implications for patient care.
- Clinical implications of human papillomavirus in head and neck Cancers.
- Human papillomavirus-associated head and neck Cancer is a distinct epidemiologic, clinical, and molecular entity.
- Gender differences in sexual biomarkers and behaviors associated with human papillomavirus-16, -18, and -33 seroprevalence.
- Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus.
- Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin.
- A new link between Fanconi Anemia and human papillomavirus-associated malignancies.
- Development of HPV vaccines for HPV-associated head and neck squamous Cell carcinoma.
- Chapter 9: Role of mucosal human papillomavirus in nongenital Cancers.
- Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the Oral cavity.
- HPV and its effect on head and neck Cancer prognosis.
- Automated high throughput DNA isolation for detection of human papillomavirus in Oral rinse samples.
- Moderate predictive value of demographic and behavioral characteristics for a diagnosis of HPV16-positive and HPV16-negative head and neck Cancer.
- Chapter 16: HPV vaccines in immunocompromised women and men.
- HPV and prognosis for patients with oropharynx Cancer.
- A causal role for human papillomavirus in head and neck Cancer.
- Karyoplasmic interaction selection strategy: a general strategy to detect protein-protein interactions in mammalian Cells.
- Discrimination between related DNA sites by a single amino acid residue of Myc-related basic-helix-loop-helix proteins.
- Human herpesvirus-8.
- Human papillomavirus in head and neck squamous Cell carcinoma: are some head and neck cancers a sexually transmitted disease?
- Larynx preservation in head and neck Cancers. A discussion of the National Comprehensive Cancer Network Practice Guidelines.
- Evidence for a causal association between human papillomavirus and a subset of head and neck Cancers.
- Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous Cell carcinoma.
- Human papillomavirus-associated head and neck squamous Cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck ca...
- Oral Human Papillomavirus (HPV) Infection among Unvaccinated High-Risk Young Adults.
Schools
Johns Hopkins University School Of Medicine
Johns Hopkins Hospital
Massachusetts General Hospital
Conditions Treated
- Anemia
- Basal Cell Carcinoma
- Carcinoma in Situ
- Coagulation Disorders (incl. Hemophilia)
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- CareSource
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health America PPO
- First Health (Coventry Health Care) PPO
- Humana
- Medical Mutual of Ohio POS
- Medicare MCR
- Molina
- MultiPlan PPO
- PHCS Network PPO
- Mutual of Omaha
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
- Elected Member
Education
-
Johns Hopkins University -
Johns Hopkins University School of Medicine
Hospital
-
Ohio State University Wexner Medical Center
Drug Facts
| NPI NUMBER | 1760436927 | |
| NPPES Provider LastName | GILLISON | |
| NPPES Provider FirstName | MAURA | |
| NPPES Provider ZIPCode | 432101280 | |
| NPPES Provider State | OH | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 36.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 12.0 | |
| Percent Opioid Claims | 33.33 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1760436927 |
| Last Name Of The Provider | GILLISON |
| First Name Of The Provider | MAURA |
| View All |
Similar Doctors
|
Dr. William J. Hicks, MD |
|
Dr. Anterpreet Neki, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. John P. Kuebler, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Manisha H. Shah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cassandra N. Grenade, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard M. Goldberg, MD |
|
Dr. Michael A. Caligiuri, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jennifer A. Woyach, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Rebecca J. Klisovic, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Miguel A. Villalona-Calero, MD
This Doctor is OpenDoctor Recommended.
|